Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations

AIM: We assessed the dosage strengths of paliperidone palmitate 1‐month (PP1M) long‐acting injectable resulting in similar steady‐state (SS) exposures to the dosage strengths of oral risperidone using pharmacokinetic (PK) simulations. METHODS: Population PK simulations of SS PK were performed using...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Clin Pract
Autors principals: Russu, Alberto, Kern Sliwa, Jennifer, Ravenstijn, Paulien, Singh, Arun, Mathews, Maju, Kim, Edward, Gopal, Srihari
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Psychiatry
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175146/
https://ncbi.nlm.nih.gov/pubmed/29707876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.13089
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars